American Society of Addiction Medicine
American Society of Addiction Medicine
Lead: Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths
Lead: Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths
Lead: Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths
Tuesday 25th June 2024
Explore community-based trials to reduce opioid overdose deaths, behavioural health impacts, and innovative addiction treatments in this engaging episode.
6 minutes
Informative
Educational
Supportive
Hopeful
Engaging
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
131 (View all)
Do you want to link to this podcast?
Get the buttons here!Community Interventions to Combat Opioid Overdose Deaths
Episode Overview
- Community-engaged interventions can reduce opioid overdose deaths.
- Access to naloxone and medications like methadone lowers overdose risks.
- Nicotine-containing e-cigarettes are effective for smoking cessation.
- Digital tools can predict stress and cravings in SUD recovery.
- Insomnia significantly affects opioid use disorder recovery.
The CTH community-engaged intervention with its leveraging of community coalitions and a data-driven approach can bring about meaningful progress.
This episode of 'This Week in Addiction Medicine from ASAM' takes a deep dive into the Community-Based Cluster-Randomized Trial aimed at reducing opioid overdose deaths. The trial, featured in the New England Journal of Medicine, examines the HEALing Communities Study, which focuses on community-engaged, data-driven interventions to tackle opioid-related deaths. The episode explores how these communities implemented a myriad of strategies, including opioid overdose education, naloxone distribution, and the use of medications for opioid use disorder.
Despite no significant differences between groups, the trial highlights meaningful progress in implementing evidence-based practices. Host Zach Caruso also discusses a JAMA Internal Medicine study about the impact of behavioural health services and medications for opioid use disorder on reducing fatal overdoses. Findings suggest that access to naloxone and treatments like methadone and buprenorphine can significantly lower overdose risks. The episode also covers a study comparing the effectiveness of nicotine-containing electronic cigarettes and varenicline for smoking cessation.
Both were found effective, offering hope for those trying to quit smoking. Another fascinating segment looks at a digital tool designed to detect stress and cravings in substance use disorder recovery. Using smartwatch data and machine learning, the tool showed promising accuracy in predicting episodes of stress and craving.
The podcast further delves into the role of insomnia in opioid use disorder recovery, comparing methadone policies between France and the U.S., and the potential benefits of extended-release injectable buprenorphine for adolescents. If you're interested in cutting-edge addiction medicine research and practical interventions, this episode is a must-listen. It's packed with valuable insights and real-world applications that could make a difference in your community.